Moody National Bank Trust Division’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-922
Closed -$403K 573
2023
Q3
$403K Hold
922
0.03% 438
2023
Q2
$463K Hold
922
0.03% 398
2023
Q1
$461K Hold
922
0.04% 388
2022
Q4
$376K Buy
922
+34
+4% +$13.2K 0.03% 426
2022
Q3
$289K Hold
888
0.03% 480
2022
Q2
$311K Buy
+888
New +$362K 0.03% 396
2022
Q1
Sell
-346
Closed -$228K 375
2021
Q4
$228K Hold
346
0.01% 348
2021
Q3
$215K Hold
346
﹤0.01% 394
2021
Q2
$219K Buy
+346
New +$191K ﹤0.01% 389
2019
Q2
Sell
-96
Closed -$21K 653
2019
Q1
$21K Buy
96
+23
+32% +$4.75K ﹤0.01% 539
2018
Q4
$14K Buy
+73
New +$15K ﹤0.01% 543

Other funds holding IDXX

Moody National Bank Trust Division's IDXX Position: Q4 2023 in Review

Moody National Bank Trust Division sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 922 shares — an estimated $403K sold.

Moody National Bank Trust Division first reported a position in IDXX in Q4 2018 and held it in 11 quarters. The position peaked at $463K in Q2 2023. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • Moody National Bank Trust Division reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
  • Moody National Bank Trust Division sold 922 Idexx Laboratories shares in Q4 2023, an estimated $403K.
  • Moody National Bank Trust Division first reported a position in Idexx Laboratories in Q4 2018 and held it in 11 quarters.
  • Moody National Bank Trust Division's Idexx Laboratories position peaked at $463K in Q2 2023.
  • 1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Moody National Bank Trust Division's 13F filing for Q4 2023, filed 11 Jan 2024.